Combined single-clade candidate HIV-1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference. by Larke, N, Im, E, Wagner, R, Williamson, C, Williamson, A, Mcmichael, A, Hanke, T

Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine. by Hanke, T, Barnfield, C, Wee, E, Agren, L, Samuel, R, Larke, N, Liljeström, P

Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen. by Larke, N, Murphy, A, Wirblich, C, Teoh, D, Estcourt, M, Mcmichael, A, Roy, P, Hanke, T